Trial reportBMC nephrology2026
The accuracy of ultrasound viscoelastic imaging in evaluating renal fibrosis and interstitial inflammation of chronic kidney disease.
Trial report in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06961162 (A Prospective, Single-Center Study), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Prospective, Single-Center Study: Evaluation of Chronic Kidney Disease Severity Using Ultrasonic Viscoelastic Parameters Combined With Clinical Indicators-With Histopathological Results as Gold Standard
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundAccurate evaluation of renal fibrosis and interstitial inflammation grades is necessary to improve the prognosis of patients with chronic kidney disease (CKD). However, non-invasive and accurate diagnostic methods are lacking. In this regard, shear wave elastography, which measures tissue viscosity and elasticity, may be a promising alternative. Therefore, this study aimed to evaluate the diagnostic performance of individual viscoelastic parameters, combined viscoelastic parameter models, and combined clinical parameter models in assessing the grades of renal fibrosis and interstitial inflammation.
methodsThis prospective study recruited 22 and 47 patients with CKD in the reproducibility and validity trials, respectively, between October 2023 and June 2024. The mean elasticity (Emean), maximum elasticity (Emax), minimum elasticity (Emin), and mean viscosity (Vmean) were obtained using two-dimensional shear-wave elastography (2D-SWE). The biopsy specimens were assessed to determine the grades of renal fibrosis and interstitial inflammation. Additionally, clinical data, including protein-to-creatinine ratio, and estimated glomerular filtration rate (eGFR), were obtained from the patients’ medical records. Multiple logistic regression models were constructed, including viscoelastic models and clinical models, and their diagnostic performance was evaluated using receiver operating characteristic curves.
resultsThe Emean, Emax, Emin and Vmean demonstrated good to excellent intra-observer consistency (ICCs = 0.839–0.929, p < 0.001). The area under the curve (AUC) of Emax combined with Vmean was not significantly superior to that of Emax alone in distinguishing fibrosis grades (0.740 [95% confidence interval (CI): 0.591–0.857] vs. 0.737 [95% CI: 0.589–0.855], p > 0.05). In contrast, Emax combined with eGFR demonstrated an AUC of 0.902 (95% CI: 0.780–0.969), a sensitivity of 93.3%, and a specificity of 84.4% in distinguishing fibrosis grades. Individual Vmean achieved an AUC of 0.919 (95% CI: 0.801–0.978), a sensitivity of 100%, and a specificity of 86.1% in differentiating between the grades of renal interstitial inflammation.
conclusionsA combination of Emax and eGFR was useful for detecting severe renal fibrosis. Additionally, Vmean was identified as a potentially useful parameter for differentiating interstitial inflammation grades, although this finding requires validation in larger cohorts given the limited samples with severe interstitial inflammation. TRIAL REGISTRATION (RETROSPECTIVELY REGISTERED): NCT06961162. Registration date: 2025-04-29.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.